GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Other Long Term Assets

Honz Pharmaceutical Co (SZSE:300086) Other Long Term Assets : ¥369.8 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co Other Long Term Assets?

Honz Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2024 was ¥369.8 Mil.

Honz Pharmaceutical Co's quarterly other long-term assets declined from Sep. 2023 (¥361.9 Mil) to Dec. 2023 (¥344.9 Mil) but then increased from Dec. 2023 (¥344.9 Mil) to Mar. 2024 (¥369.8 Mil).

Honz Pharmaceutical Co's annual other long-term assets declined from Dec. 2021 (¥489.6 Mil) to Dec. 2022 (¥443.7 Mil) and declined from Dec. 2022 (¥443.7 Mil) to Dec. 2023 (¥344.9 Mil).

Honz Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Honz Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honz Pharmaceutical Co Other Long Term Assets Chart

Honz Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 472.84 496.33 489.60 443.69 344.94

Honz Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 420.71 392.24 361.87 344.94 369.80

Honz Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Honz Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » Other Long Term Assets
Comparable Companies
SZSE:002370 SHSE:600080 SHSE:600513 SZSE:002365 SZSE:002817 SZSE:300519 SZSE:002693 SZSE:301331 BJSE:830946 SZSE:300254 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095
Website
http://www.honz.com.cn
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Executives
Wang Chun Ying Supervisors
Rui Shou Hong Director
Hong Jiang You Directors, executives
Hong Zhi Hui Director
He Zi Qun Supervisors
Hong Li Ping Directors, executives
Hong Jiang Tao Director
Liu Hui Liang Executives
Hu Fei Hong Director
Li Ping Independent director
Fu Lin Jun Director

Honz Pharmaceutical Co Headlines

No Headlines